NIAID chemokine discovery may chart new course for HIV
This article was originally published in Scrip
Executive Summary
Like most stories of discovery, the unearthing by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) of a link between the protein CXCL4 and HIV suppression may still be far from a happy ending, in this case, potential translation into an effective treatment, preventive therapy or vaccine, explained Dr Paolo Lusso, chief of the viral pathogenesis section in the agency's Laboratory of Immunoregulation Scientists directed by NIAID chief Dr Anthony Fauci.